CIK 0001699382 · Non-accelerated filer<br>Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463218129
- Phone
- (609) 642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-13 | Jalota Deepika Chief Development Officer | Returned to the company · Employee Stock Option (right to buy) | −125,000 | 0 | ||
| 2024-08-13 | Jalota Deepika Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-08-13 | Carulli Michael Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy) | −13,605 | 0 | ||
| 2024-08-13 | Carulli Michael Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy) | −27,200 | 0 | ||
| 2024-08-13 | Carulli Michael Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +40,805 | 40,805 | ||
| 2024-08-13 | Carulli Michael Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy) | −75,000 | 75,000 | ||
| 2024-08-13 | Carulli Michael Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2024-08-13 | Mack David Henry President and CEO | Returned to the company · Employee Stock Option (right to buy) | −134,584 | 0 | ||
| 2024-08-13 | Mack David Henry President and CEO | Returned to the company · Employee Stock Option (right to buy) | −249,600 | 0 | ||
| 2024-08-13 | Mack David Henry President and CEO | Grant or award · Employee Stock Option (right to buy) | +384,184 | 384,184 | ||
| 2024-08-13 | Mack David Henry President and CEO | Returned to the company · Employee Stock Option (right to buy) | −330,000 | 0 | ||
| 2024-08-13 | Mack David Henry President and CEO | Grant or award · Employee Stock Option (right to buy) | +330,000 | 330,000 | ||
| 2024-06-07 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | −67,500 | 0 | ||
| 2024-06-07 | Gallagher Carol Giltner Director | Gift · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2024-06-06 | Stelzer Laurie Director | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2024-06-06 | LEVINE ARNOLD J Director | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2024-06-06 | Heyman Richard A. Director | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2024-06-06 | Gallagher Carol Giltner Director | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2024-06-06 | FLOWERS KIRSTEN Director | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2024-06-06 | BAUM CHARLES M Director | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 |
Page 3 of 10 · 196 trades